ArticleProbiotics and antimicrobial proteins2026
Lacticaseibacillus Strains Shape Intestinal Immune Homeostasis by Promoting Antimicrobial Activity and Modulating Antigen-Presenting Cells.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Probiotics enhance intestinal defense through immune modulation, barrier reinforcement, and the induction of endogenous antimicrobial proteins. Understanding how specific strains coordinate these mechanisms is essential for their rational application in biomedical and functional food contexts.We investigated whether oral administration of Lacticaseibacillus casei CRL 431 and Lacticaseibacillus paracasei CNCM I-1518 promotes endogenous antimicrobial peptide production and shapes mucosal immune responses. Using a murine supplementation model, we evaluated epithelial barrier integrity, Goblet and Paneth cell responses, cytokine profiles, and the antimicrobial activity of intestinal fluids. In parallel, in vitro assays examined the effects of soluble intestinal factors from probiotic-fed mice on immune cell chemotaxis, antigen-presenting cell maturation, and macrophage survival under oxidative stress.Both probiotic strains increased Goblet cell numbers and tight junction protein expression without altering paracellular permeability. Notably, intestinal fluids from probiotic-fed mice exhibited robust antimicrobial activity associated with Paneth cell activation and enhanced production of enteric α-defensin 5. In addition, probiotic supplementation induced a balanced immune response, characterized by increased pro-inflammatory cytokines (IL-6, IFN-γ, TNF-α) together with IL-10. Importantly, soluble factors from probiotic-fed mice promoted macrophage and T cell chemotaxis, enhanced antigen-presenting cell maturation and cytokine secretion, and improved macrophages survival under oxidative stress.These findings indicate that these probiotic strains induce intestinal changes by integrating antimicrobial peptide production with immune modulation. By demonstrating that probiotic consumption enhances endogenous antimicrobial activity and soluble factor-mediated immune modulation, this study provides mechanistic insights relevant to probiotic-based strategies aimed at strengthening mucosal defenses and limiting pathogen colonization.
Indexed as
Identifiers
42501277What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.